Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Ecka Health vs Harbor

By GLP-1 ScorecardUpdated

Ecka HealthFactor scores assessed November 2026.
Site position #112

Lower score

HarborFactor scores not reassessed.
Site position #94

Higher score

Score comparison

Harbor has the higher recorded score — 72/100 to 70.6/100, but only just.

Harbor grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Harbor is a physician-led telehealth platform offering compounded semaglutide (from $99/mo) and compounded tirzepatide (from $149/mo) — among the lowest headline prices in the market. Ecka Health is close behind and may still be the better fit — see the factor split below.

Before you choose

Before comparing the headline prices, the Ecka Health review and the Harbor review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.

If neither one fits, Ecka Health vs Nucific and Harbor vs Live Vital compare each of them with another graded program, and the list of alternatives to Ecka Health ranks the programs closest to Ecka Health on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

Of the sellers that pay us a commission, the GoodLife Health review covers one graded close to these two, at 69.8/100. That relationship never changes a grade, and the review lists what we could not verify.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueEcka Health +10
84
74
Dose & formulationEcka Health +21
85
64
Clinical oversightHarbor +21
68
89
Labs & monitoringHarbor +12
51
63
FulfillmentHarbor +16
65
81
Contract termsHarbor +2
45
47
Ecka Health · top barHarbor · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricEcka HealthHarbor
WeighScore70.6/10072/100
GradeCC
Site position#112#94
Semaglutide$99/mo billed annually, $124 semi-annually, $149 quarterly or $199 month-to-month (same price at every dose, compounded)$99/mo (starting dose, compounded)
Tirzepatide$199/mo billed annually, $224 semi-annually, $249 quarterly or $299 month-to-month (same price at every dose, compounded)$149/mo (starting dose, compounded)
CoverageAdvertised as nationwide; no state listCoverage not published
Brand-name accessYesNot confirmed
Oral / sublingualNot confirmedNot confirmed
Ecka Health

Site position #112 · C

Factor scores assessed November 2026.

Strengths

  • Names its prescribing physicians
  • Offers brand Zepbound alongside compounded options
  • Shows a LegitScript seal

What to consider

  • The lowest prices require annual billing; month-to-month costs $100 more
  • No legal company name, address or dispensing pharmacy is published
  • The banner says cancel anytime, but the terms keep a paid term and dispensed medication non-refundable
  • Approved orders are final and not refundable
Harbor

Site position #94 · C

Factor scores not reassessed.

Strengths

  • Compounded semaglutide from $99/mo and tirzepatide from $149/mo — among the lowest headline prices in the market
  • LegitScript certified with 4.7-star rating, 94.6% success rate, and 10,000+ verified members
  • 24/7 physician access with ongoing consultations, dosage adjustments, and free discreet shipping
  • 12-Month Money Back Guarantee if you don't reach your weight-loss goal
  • HSA/FSA eligible; no hidden fees, no insurance billed

What to consider

  • Compounded medications are not FDA-approved; compounding pharmacy names not publicly disclosed
  • Dietitian support offered only post-program (maintenance phase), not during active treatment
  • State-specific consultation types vary; nationwide availability unconfirmed for all states
  • No labs disclosed; patient portal is a third-party platform (mdintegrations), not native
  • Newer brand; success rate and member counts are on-site claims, not third-party verified

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard